Miniatura

Fitxers

711883.pdf (418.77 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2021-04-23

Llicència de publicació

cc-by-nc (c) Darbà, Josep et al., 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/185058

Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.2147/CEOR.S306389

Resum

Objective: To determine the economic impact of the fraction of exhaled nitric oxide (FeNO) in asthma diagnosis and management in primary care in Sweden. Methods: An economic model has been developed to determine the economic impact of the fraction of exhaled nitric oxide (FeNO) in asthma diagnosis and management in primary care in Sweden. The model includes the use and cost of commonly used tests, the associated outcomes and diagnostic accuracy. We compared FeNO with spirometry and reversibility testing, methacholine challenge test, allergy testing, and blood eosinophil count. One-way sensitivity analyses were performed to confirm the robustness of results. Results: Adding FeNO measurement in asthma diagnosis resulted in cost savings of SEK 672 per patient by the fourth year. The use of FeNO testing in asthma management proved to be a dominant strategy when compared with each other test except methacholine challenge test. Sensitivity analyses confirmed the robustness of the results. Conclusion: Introducing FeNO testing in clinical practice for the diagnosis and management of asthma in primary care in Sweden is less costly than standard methods while providing similar health benefits.

Matèries

Asma, Atenció primària, Gestió, Economia de la salut, Suècia

Matèries (anglès)

Asthma, Primary care, Management, Medical economics, Sweden

Citació

Col·leccions

Articles publicats en revistes (Economia)

Citació

DARBÀ, Josep, ASCANIO, Meritxell, SYK, Jörgen, ALVING, Kjell. Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden. _Clinicoeconomics and Outcomes Research_. 2021. Vol. 2021, núm. 13, pàgs. 289-297. [consulta: 22 de gener de 2026]. ISSN: 1178-6981. [Disponible a: https://hdl.handle.net/2445/185058]

Exportar metadades

JSON - METS

Compartir registre